Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

High Cholesterol (Hyperlipidemia) Clinical Trials

A listing of High Cholesterol (Hyperlipidemia) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (6) clinical trials

A research study is evaluating an investigational medication that may lower cardiovascular risk in patients who are statin intolerant. This research study may be an option if you: • Are 18 years of age or older • Are statin intolerant (defined as the inability to tolerate 2 or more statins) ...

Phase N/A

A research study is evaluating an investigational medication that may lower cardiovascular risk in patients who are statin intolerant. This research study may be an option if you: • Are 18 years of age or older • Are statin intolerant (defined as the inability to tolerate 2 or more statins) ...

Phase N/A

A research study is evaluating an investigational medication for high cholesterol and heart disease. This research study may be an option if you: • Are between 40 and 85 years of age • Have been diagnosed with high risk factors that may include: o Coronary heart disease such as a ...

Phase N/A

Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant

The purpose of this study is to determine if bempedoic acid (ETC-1002) is effective and safe versus placebo in patients with elevated LDL cholesterol and who are statin-intolerant.

Phase

Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk

The purpose of this study is to see if bemedoic acid (ETC-1002) is effective versus placebo in patients with high cardiovascular risk and elevated LDL cholesterol not adequately controlled by their current therapy.

Phase

An Extension Trial of Inclisiran Compared to Evolocumab in Participants With Cardiovascular Disease and High Cholesterol

ORION-3, an extension of study MDCO-PCS-15-01 (ORION-1) [NCT02597127], is a Phase II, placebo-controlled, double-blind, randomized trial to evaluate the efficacy, safety, and tolerability of inclisiran (ALN-PCSSC) injection(s). All participants who completed ORION-1 (at least up to and including Day 210) and meet the study criteria will be enrolled into this ...

Phase